Problem 40 - Chemistry The Central Science In Si Units

Question

A chemist at a pharmaceutical company is measuring equilibrium constants for reactions in which drug candidate molecules bind to a protein involved in cancer. The drug molecules bind the protein in a 1:1 ratio to form a drug- protein complex. The protein concentration in aqueous solution at \(25^{\circ} \mathrm{C}\) is \(1.50 \times 10^{-6} \mathrm{M}\). Drug A is introduced into the protein solution at an initial concentration of \(2.00 \times 10^{-6} \mathrm{M}\). Drug B is introduced into a separate, identical protein solution at an initial concentration of \(2.00 \times 10^{-6} \mathrm{M}\). At equilibrium, the drug A-protein solution has an A-protein complex concentration of \(1.00 \times 10^{-6} \mathrm{M}\), and the drug B solution has a B-protein complex concentration of \(1.40 \times 10^{-6} \mathrm{M}\). Calculate the \(K_{c}\) value for the A-protein binding reaction and for the B-protein binding reaction. Assuming that the drug that binds more strongly will be more effective, which drug is the better choice for further research?

Step-by-Step Solution

Answer

Drug B is the better choice for further research due to its stronger binding affinity, as indicated by a higher \(K_c\) value.

Step 1: Understanding the Conceptual Setup

The chemist is measuring equilibrium constants, denoted as \(K_c\), for two drug-protein binding reactions. These are reversible reactions where each drug binds to a protein in a 1:1 ratio to form a drug-protein complex. The equilibrium constant \(K_c\) is a measure of the strength of the binding at equilibrium.

Step 2: Formulating the Equilibrium Expression

For a general reaction \(\text{Drug} + \text{Protein} \rightleftharpoons \text{Drug-Protein Complex}\), the equilibrium constant \(K_c\) can be expressed as:\[K_c = \frac{[\text{Drug-Protein Complex}]}{[\text{Drug}][\text{Protein}]}.\]

Step 3: Solving for Drug A

For Drug A, use the given equilibrium concentrations. The complex concentration is \([\text{A-Protein Complex}] = 1.00 \times 10^{-6} \ \text{M}\). Substitute the initial concentrations of the drug and protein minus the complex concentration to find their equilibrium concentrations:- \( [\text{Drug A}]_\text{eq} = 2.00 \times 10^{-6} \text{ M} - 1.00 \times 10^{-6} \text{ M} = 1.00 \times 10^{-6} \text{ M}\),- \( [\text{Protein}]_\text{eq} = 1.50 \times 10^{-6} \text{ M} - 1.00 \times 10^{-6} \text{ M} = 0.50 \times 10^{-6} \text{ M}\).Now calculate \(K_c\):\[K_c = \frac{1.00 \times 10^{-6}}{(1.00 \times 10^{-6})(0.50 \times 10^{-6})} = 2.00 \times 10^6.\]

Step 4: Solving for Drug B

Similarly for Drug B, the equilibrium concentration of the complex is \([\text{B-Protein Complex}] = 1.40 \times 10^{-6} \ \text{M}\). Calculate equilibrium concentrations for Drug B and the protein:- \( [\text{Drug B}]_\text{eq} = 2.00 \times 10^{-6} \text{ M} - 1.40 \times 10^{-6} \text{ M} = 0.60 \times 10^{-6} \text{ M}\),- \( [\text{Protein}]_\text{eq} = 1.50 \times 10^{-6} \text{ M} - 1.40 \times 10^{-6} \text{ M} = 0.10 \times 10^{-6} \text{ M}\).Now calculate \(K_c\):\[K_c = \frac{1.40 \times 10^{-6}}{(0.60 \times 10^{-6})(0.10 \times 10^{-6})} = 2.33 \times 10^7.\]

Step 5: Comparing the Binding Strengths

Drug B has a higher equilibrium constant \(K_c = 2.33 \times 10^7\) compared to Drug A's \(K_c = 2.00 \times 10^6\). Since a higher \(K_c\) value indicates stronger binding, Drug B binds more strongly to the protein than Drug A.

Key Concepts

Drug-Protein Binding

When a drug binds to a protein, a specific kind of interaction occurs where molecules of the drug attach to the protein. This physical binding is crucial, especially in medicine, as it can affect how drugs perform in the body. The binding often happens at a specific site on the protein, suited for the drug molecule. This interaction is highly specific; meaning a small change in the drug molecule can influence the binding significantly.

Understanding this binding process is essential because it informs us how efficiently a drug can perform its intended function, such as inhibiting a protein involved in cancer. In this exercise, the drug binds in a 1:1 ratio to form a drug-protein complex, making it easier to calculate and understand the equilibrium constants involved.

Equilibrium Concentration

Equilibrium concentration refers to the concentrations of reactants and products in a chemical reaction at equilibrium, when their amounts no longer change. In the context of drug-protein binding, this concept helps us understand how much of the drug, protein, and drug-protein complex exist when the reaction has reached a state of balance.

Initially, you have known concentrations of the drug and protein. As the reaction proceeds, some of these molecules form a complex. At equilibrium, the concentration of the complex is provided, from which we can deduce the remaining concentrations of free drug and protein. This is important for calculating the equilibrium constant, as it requires the equilibrium concentrations of all reactants and products.

Equilibrium Expression

The equilibrium expression is a mathematical way to express the relationship between the concentrations of reactants and products in a reaction at equilibrium. Specifically, it gives us the equilibrium constant, denoted as \( K_c \), which is crucial for understanding how a reaction behaves at equilibrium.

For our drug-protein binding reaction, the expression is:

• \( K_c = \frac{[\text{Drug-Protein Complex}]}{[\text{Drug}][\text{Protein}]} \)

This particular expression shows the ratio of the concentration of the complex to the concentrations of the unbounded drug and protein. Higher \( K_c \) values suggest a greater tendency for the formation of the drug-protein complex, which denotes stronger binding.

Binding Strength Comparison

Comparing the binding strengths of two drugs involves looking at their equilibrium constants, \( K_c \), which express how strongly each drug binds to the protein. The larger the \( K_c \), the stronger the binding between the drug and protein.

In the given exercise, Drug B has a significantly higher \( K_c \) value than Drug A, indicating that Drug B forms a complex with the protein more efficiently. This means that Drug B binds more tightly and has a higher affinity for the protein, making it a better choice for further research if strong binding leads to better therapeutic outcomes. Such comparisons are fundamental in drug development, guiding which compounds might be more promising in subsequent stages of research.